🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Arizona › Scottsdale

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Scottsdale, AZ keessatti

Qorannoo 7 Kansaar Onnee Triple-Negative f Scottsdale fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • HonorHealth Research Institute, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07705334

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • HonorHealth, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06400472

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic in Arizona, Scottsdale
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT06635980

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic - Scottsdale, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT01042379

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Namoota walitti qabaa jiraSadarkaa 1/2
  • HonorHealth Research and Innovation Institute, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Onk-2025 · NCT06249048

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Namoota walitti qabaa jiraSadarkaa 1/2
  • HonorHealth Research Institute, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Sad-2024 · NCT04787042

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • HonorHealth Research Institute, Scottsdale
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Gur-2024 · NCT04282044

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Scottsdale keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.